460 Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CE–22–002, 

Grants to Support New Investigators in 

Conducting Research Related to Preventing 

Interpersonal Violence Impacting Children 

and Youth. 

Dates: March 8–9, 2022. 

Times: 8:30 a.m.–5:30 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Aisha L. 

Wilkes, M.P.H., Scientific Review Officer, 

National Center for Injury Prevention and 

Control, CDC, 4770 Buford Highway NE, 

Mailstop S106–9, Atlanta, Georgia 30341– 

3717, Telephone: (404) 639–6473, Email: 

AWilkes@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–28522 Filed 1–4–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CE–22–001, 

Grants to Support New Investigators in 

Conducting Research Related to 

Understanding Polydrug Use Risk and 

Protective Factors. 

Dates: March 15–16, 2022. 

Times: 8:30 a.m.–5:30 p.m., EDT. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Aisha L. 

Wilkes, M.P.H., Scientific Review Officer, 

National Center for Injury Prevention and 

Control, CDC, 4770 Buford Highway NE, 

Mailstop S106–9, Atlanta, Georgia 30341– 

3717, Telephone: (404) 639–6473, Email: 

AWilkes@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–28523 Filed 1–4–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—Funding Opportunity 

Announcement (FOA), PAR 20–280, 

Cooperative Research Agreements Related to 

the World Trade Center Health Program 

(U01); and RFA OH–22–004, World Trade 

Center Health Research related to WTC 

Survivors (U01—No Applications with 

Responders Accepted). 

Dates: March 22–23, 2022. 

Times: 11:00 a.m.–5:00 p.m., EDT. 

Place: Virtual. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Laurel 

Garrison, M.P.H., Scientific Review Officer, 

National Institute for Occupational Safety 

and Health, CDC, 5555 Ridge Avenue, 

Cincinnati, Ohio 45213, Telephone: (513) 

533–8324, Email: LGarrison@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–28524 Filed 1–4–22; 8:45 am] 

BILLING CODE 4163–18–P 


TKELLEY on DSK125TN23PROD with NOTICE